I have followed this fairly closely for a couple of years now. Like a lot of the "we will update shareholders in due course" items, they provide no update. They never do.
All I think is that nothing major is happening. No update on that USD200K from the Philippines, no update on the Unilever order, no director buying... just nothing.
They will have to raise capital at some stage in the next 9 months, the success of this has little to do with the momentum of the company but moreso to do with the sustainability of this raging bull market in fluff. Given the massive failure of their last raise I'd like to think their credibility is shot. My mind will change if they can raise capital because that would mean they've probably found a real backer and not some shonky flip-flopper dressed up as a disruptive capital raising platform!
- Forums
- ASX - By Stock
- Ann: Appendix 4C and Quarterly Report
RAN
range international limited
Add to My Watchlist
0.00%
!
0.2¢

I have followed this fairly closely for a couple of years now....
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.878M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 4938403 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 2070004 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 4938403 | 0.002 |
23 | 50444769 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 2070004 | 6 |
0.004 | 1155263 | 3 |
0.005 | 2454695 | 3 |
0.006 | 2185526 | 2 |
0.007 | 244444 | 1 |
Last trade - 16.21pm 04/07/2025 (20 minute delay) ? |
Featured News
RAN (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online